Cue biopharma to host business update call and webcast for ongoing cue-101 clinical trials

Cambridge, mass., jan. 20, 2022 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted t cells directly within the patient's body, announced today it will host a conference call and webcast to provide a clinical update on wednesday, january 26, 2022 at 4:30 p.m. est. live and archived versions of the event can be accessed via the company's website.
CUE Ratings Summary
CUE Quant Ranking